Ranbaxy may gain from US court's Cipro verdict
Hyderbad based Dr Reddy's Laboratories' loss could well be Ranbaxy's gain after a lawsuit challenging German drugmaker Bayer AG's US patent on antibiotic ciprofloxacin till December 2003 was rejected
Hyderbad based Dr Reddy's Laboratories' loss could well be Ranbaxy's gain after a lawsuit challenging German drugmaker Bayer AG's US patent on antibiotic ciprofloxacin till December 2003 was rejected